Benjamin Turner

39 papers receiving 957 citations

Benjamin Turner's Hit Papers

Is it time to target no evident disease activity (NEDA) in multiple sclerosis? 2015 · 280 citations
2800+3+7Years since publication50100150200250

Peers

Benjamin Turner
Comparison fields: 5 of 85
  • Pathology and Forensic Medicine 676
  • Neurology 192
  • Rheumatology 120
  • Developmental Neuroscience 25
  • Oncology 158
Replace Virginia Devonshire with:
Virginia Devonshire Canada
James Stankiewicz United States
Claire Hirst United Kingdom
P. O’Connor Canada
Gina Remington United States
Peter Huppke Germany
Nebojša Stojsavljević Serbia
Suzanne Gazda United States
E. Verdun Italy
Élisabeth Maillart France
Benjamin Turner relative to Virginia Devonshire Canada Virginia Devonshire's profile →
Citations per field
00.5×1.5×1.9×
Virginia Devonshire · 1×
Citations per year

Countries citing papers authored by Benjamin Turner

Since Specialization
Citations

This map shows the geographic impact of Benjamin Turner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Turner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Turner more than expected).

Fields of papers citing papers by Benjamin Turner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin Turner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Turner. The network helps show where Benjamin Turner may publish in the future.

Co-authors

The 25 scholars most cited alongside Benjamin Turner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Benjamin Turner Line = papers co-authored together Benjamin Turner links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Is it time to target no evident disease activity (NEDA) in multiple sclerosis?
Hit paper breakdown →
2015280
2 2015103
3 201877
4 201962
5 200355
6 201747
7 201146
8 201643
9 201640
10 202038
11 202331
12 201828
13 201716
14 202015
15 201011
16 201711
17 20189
18 20187
19 20206
20 20235

About Benjamin Turner

Benjamin Turner is a scholar working on Pathology and Forensic Medicine, Rheumatology, Neurology, Public Health, Environmental and Occupational Health and Infectious Diseases, having authored 42 papers that have together received 973 indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (24 papers), Polyomavirus and related diseases (4 papers), Acute Lymphoblastic Leukemia research (4 papers), Peripheral Neuropathies and Disorders (4 papers), Chronic Lymphocytic Leukemia Research (4 papers), Systemic Lupus Erythematosus Research (3 papers), HIV/AIDS drug development and treatment (2 papers) and Rheumatoid Arthritis Research and Therapies (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (676 citations), Neurology (192 citations), Rheumatology (120 citations), Developmental Neuroscience (25 citations) and Oncology (158 citations). Benjamin Turner has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include Klaus Schmierer, Gavin Giovannoni, Mónica Marta, Sharmilee Gnanapavan, Curtis Offiah, Daniel R. Altmann, David Baker, Gunnar Juliusson, Jeremy Chataway and Julia Pakpoor. Their work appears in journals such as Multiple Sclerosis and Related Disorders, Multiple Sclerosis Journal, Neurology, Journal of Neurology Neurosurgery & Psychiatry and Neurology Neuroimmunology & Neuroinflammation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact